Imagine hassle-free oncology clinical trials
PSI’s key differentiator is our ability to plan and execute complex clinical trials on time, saving our customers millions of development dollars.
The PSI Story
PSI today is the largest CRO of its size (over 2,000 employees) that is still, after 25 years, privately owned by its management. With zero outside investment or debt, PSI has been independent, consistent, and stable. The company has always grown organically through deliberate hiring and training.
PSI operates in 50 countries with offices all across North America, Europe (East and West), Russia, India, South Africa, Latin America, and Asia Pacific.
Customer and staff loyalty are at the core of PSI’s growth. “We want to be the best CRO in the world as measured by our employees, customers, sites and vendors” reads PSI’s mission statement.
Our low staff turnover rates allow clients to work with the same study teams from one study to the next. Every Patient Counts” is PSI’s operational mantra.
PSI’s key differentiator is our consistent ability to plan and execute complex oncology trials on time, saving our customers millions of development dollars.
PSI’s exceptionally high repeat business is our key measure of success.
“PSI has been exceedingly professional and is respected by our site as a great collaborator.” Anthony W. Tolcher, MD, FRCP, FACP